NIH (05/04) – Dr. Linda Dwoskin feels just one small step away from success in her effort to develop the first-ever medication to treat methamphetamine addiction. She and colleagues at the Universities of Kentucky and Arkansas have created a molecule that blocks methamphetamine’s addictive effects and completed preclinical testing without raising any red flags for undesirable side effects. Read more